Abstract: A pharmaceutical composition includes a retinylamine derivative having the following formula (I): where R1 is an amino acid residue, a dipeptide or a tripeptide that is linked to the retinylamine by an amide bond.

Abstract: A compound includes at least one targeting peptide coupled to a detectable moiety. The targeting peptide binds to EDB-FN or EDA-FN and includes at least one of amino acid sequence selected from the group consisting of SEQ ID NOs: 1-30.

Abstract: A composition includes a polysaccharide at least one retinoid linked to at least one monosaccharide subunit of the polysaccharide with a covalent linkage. The linkage being degradable by hydrolysis during digestion of the composition to provide controlled, delayed, and/or sustained delivery of the at least one retinoid upon enteral administration of the composition to a subject.

Abstract: Aspects of the subject disclosure may include, for example, a device including a processing system that receives items of media content; delivers the items over a network according to a schedule determined by a content delivery scheduling system; detects a level of broadcast network capacity utilization; and periodically generates and transmits to the scheduling system a forecast of network capacity utilization. A new forecast is generated and transmitted responsive to the network capacity utilization deviating from the forecast by more than a predetermined tolerance. A resource for delivering the items of media content is dynamically assigned to the processing system by the scheduling system in accordance with a current forecast. The items of media content comprise a queue accessible to the content delivery scheduling system; the queue is maintained by the scheduling system and is uniquely assigned to the processing system. Other embodiments are disclosed.

Abstract: A compound comprising formula (I): wherein R1 is an alkylamino group or a group containing at least one aromatic group; R2 and R3 are independently an aliphatic group or hydrophobic group; R4 and R5 are independently H, a substituted or unsubstituted alkyl group, an alkenyl group, an acyl group, or an aromatic group, or includes a polymer, a targeting group, or a detectable moiety, and at least one of R4 and R5 includes a targeting group that targets and/or binds to a retinal or visual protein; a, b, c, and d are independently an integer from 1 to 10; and pharmaceutically acceptable salts thereof.

Abstract: A composition includes a polysaccharide at least one retinoid linked to at least one monosaccharide subunit of the polysaccharide with a covalent linkage. The linkage being degradable by hydrolysis during digestion of the composition to provide controlled, delayed, and/or sustained delivery of the at least one retinoid upon enteral administration of the composition to a subject.

Abstract: A compound includes at least one targeting peptide coupled to a detectable moiety. The targeting peptide binds to EDB-FN or EDA-FN and includes at least one of amino acid sequence selected from the group consisting of SEQ ID NOs: 1-30.

Abstract: Aspects of the subject disclosure may include, for example, a device including a processing system that receives items of media content; delivers the items over a network according to a schedule determined by a content delivery scheduling system; detects a level of broadcast network capacity utilization; and periodically generates and transmits to the scheduling system a forecast of network capacity utilization. A new forecast is generated and transmitted responsive to the network capacity utilization deviating from the forecast by more than a predetermined tolerance. A resource for delivering the items of media content is dynamically assigned to the processing system by the scheduling system in accordance with a current forecast. The items of media content comprise a queue accessible to the content delivery scheduling system; the queue is maintained by the scheduling system and is uniquely assigned to the processing system. Other embodiments are disclosed.

Abstract: A molecular probe includes the following formula: P-L-C wherein P is a EDB-FN targeting peptide, C is a contrast agent; and L is a non-peptide linker that covalently links the peptide to the contrast agent.

Abstract: An optoelectronic modulation stack includes a substrate, a plurality of touch sensing units, at least a first anti-interference spot and a nano-structural layer. The touch sensing units are coplanarly disposed on the substrate, and a first interval region is formed between the adjacent touch sensing units. The first anti-interference spot is disposed within the first interval region, and the width of the first anti-interference spot is substantially less than that of the substrate or touch sensing unit. The nano-structural layer is disposed below the first anti-interference spot and includes a plurality of nano structures. When the light passes through the nano structures and the first anti-interference spot, the optical characteristic of the light is changed.

Abstract: A manufacturing method of an anti-interference flexible electronic structure formed by a carrier separation process comprises the steps of: providing a carrier; attaching a flexible substrate to the carrier; forming a plurality of touch-sensing units coplanarly on the flexible substrate, wherein a first interval region is formed between the adjacent touch-sensing units; coplanarly forming at least a first anti-interference spot within the first interval region, wherein a distance is between the first anti-interference spot and the adjacent touch-sensing unit; and separating the flexible substrate from the carrier.

Abstract: The present invention relates to a method, apparatus for generating a fused ultrasonic image and an ultrasound machine. The method comprises: acquiring an ultrasonic image of PW mode; acquiring an ultrasonic image of M mode; and superimposing the ultrasonic image of PW mode to a corresponding position of the ultrasonic image of M mode to generate a fused ultrasonic image.

Abstract: A compound includes at least one targeting peptide coupled to a detectable moiety. The targeting peptide binds to EDB-FN or EDA-FN and includes at least one of amino acid sequence selected from the group consisting of SEQ ID NOs: 1-30.

Abstract: A pharmaceutical composition includes a retinylamine derivative having the following formula (I): where R1 is an amino acid residue, a dipeptide or a tripeptide that is linked to the retinylamine by an amide bond.

Abstract: A smart monitor system includes a hand-held electronic device and a monitor. The hand-held electronic device includes a panel, a control unit, a touch-sensing cover and a wireless communication unit. The touch-sensing cover has a cover and a touch-sensing structure. The cover is disposed on the side of the hand-held electronic device opposite the panel. Partial or total area of the touch-sensing structure is disposed on the cover. The touch-sensing structure is electrically connected to the control unit. The wireless communication unit has a wireless communication chip and an antenna. The wireless communication chip is electrically connected to the control unit, and the antenna is disposed on the touch-sensing cover. The smart monitor system can communicate with and controls the monitor through the hand-held electronic device for various application.

Abstract: Biodegradable computed tomography (CT) contrast agents comprising a polyiodinated aryl contrast agent that is crosslinked by an organic disulfide are described herein. The contrast agents can be used to image a tissue region by administering an effective amount of the biodegradable CT contrast agent to a subject, allowing a sufficient amount of time for the biodegradable CT contrast agent to enter the tissue region, and performing x-ray computed tomography imaging of the tissue region of the subject.

Abstract: A laser etching method for a transparent conductive plate includes the steps as follows: providing a transparent conductive plate having a transparent conductive layer; continuingly emitting a plurality of laser beams to the transparent conductive layer, and controlling the center points of the laser beams to move in a front path and a rear path partially overlapping a beginning portion of the front path for forming an end connection groove connecting the beginning and the end thereof, or controlling the center points of the laser beams to move in a transverse path and a longitudinal path without overlapping the transverse path for forming a T-shaped groove, or controlling the center points of the laser beams to sequentially move in a first path, a curve path, and a second path substantially perpendicular to the first path for forming a curve groove.

Abstract: A laser etching method for a transparent conductive plate includes the steps as follows: providing a transparent conductive plate having a transparent conductive layer; continuingly emitting a plurality of laser beams to the transparent conductive layer, and controlling the center points of the laser beams to move in a front path and a rear path partially overlapping a beginning portion of the front path for forming an end connection groove connecting the beginning and the end thereof, or controlling the center points of the laser beams to move in a transverse path and a longitudinal path without overlapping the transverse path for forming a T-shaped groove, or controlling the center points of the laser beams to sequentially move in a first path, a curve path, and a second path substantially perpendicular to the first path for forming a curve groove.

Abstract: A compound comprising formula (I): wherein R1 is an akylamino group or a group containing at least one aromatic group; R2 and R3 are independently an aliphatic group or hydrophobic group; R4 and R5 are independently H, a substituted or unsubstituted akyl group, an akenyl group, an acyl group, an aromatic group, polymer, a targeting group, or a detectable moiety; a, b, c, and d are independently an integer from 1 to 10; and pharmaceutically acceptable salts thereof.

Abstract: A manufacturing method of an anti-interference flexible electronic structure formed by a carrier separation process comprises the steps of: providing a carrier; attaching a flexible substrate to the carrier; forming a plurality of touch-sensing units coplanarly on the flexible substrate, wherein a first interval region is formed between the adjacent touch-sensing units; coplanarly forming at least a first anti-interference spot within the first interval region, wherein a distance is between the first anti-interference spot and the adjacent touch-sensing unit; and separating the flexible substrate from the carrier.